NCT00032916

UnknownPhase 1

Drug Interaction Study With NS2359 and Cocaine in Cocaine Ex...

National Institute on Drug Abuse (NIDA)Source

Compare

Other study identifiers

Sponsor study identifier

NIDA-CPU-2359-02-1

Study Type

interventional

Reported enrollment (type unavailable)

24

Locations

1 country

Sites

1

Timeline

Study Start

June 2001

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

Not reported

Date not reported

Study Completion

December 2002

Date type not reported

This date has not been verified as actual or estimated.

Brief Summary

The purpose of this study is to conduct a drug interaction study with NS2359 and cocaine in cocaine experienced volunteers.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: unknown
Reported enrollment (type unavailable): 24 participants
Study completion date: December 2002
Date type not reported
This date has not been verified as actual or estimated.
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Some registry-reported names shown below are not yet linked in this graph.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
June 2001
Date type not reported
This date has not been verified as actual or estimated.
First Submitted
April 5, 2002
Actual (reported)
First Posted
April 8, 2002
Actual (reported)
Study Completion
December 2002
Date type not reported
This date has not been verified as actual or estimated.

Last Updated: January 11, 2017
Status Verified: April 2004
Last Update Submitted: January 10, 2017

Conditions

Outcome Measures

Primary Outcomes (2)

Pharmacokinetic parameter comparison
plasma concentration

Interventions

NS2359Drug

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age18 Years - 45 Years

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64)

You may qualify if:

Male or Female, 18-45 yrs of age; females of child-bearing potential using appropriate method of birth control; be able to understand the procedure and agrees to participate via informed consent; must be cocaine dependent according to DSM-4 criteria; must be capable of providing written consent; must be able to comply with protocol requirement, CPU rules and regulations; must not be currently seeking treatment for cocaine abuse.

You may not qualify if:

Sponsors & Collaborators

National Institute on Drug Abuse (NIDA)
NIHlead

Study Sites (1)

Uniformed Services University of Health Science

Bethesda, Maryland, 20814 4799, United States

MeSH Terms

Conditions

Cocaine-Related Disorders

Interventions

GSK372475

Condition Hierarchy (Ancestors)

Substance-Related DisordersChemically-Induced DisordersMental Disorders

Study Officials

Louis Cantilena, M.D.
Uniformed Services University of Health Science
PRINCIPAL INVESTIGATOR

Study Design

Study Type: interventional
Phase: phase 1
Allocation: RANDOMIZED
Masking: DOUBLE
Purpose: TREATMENT
Sponsor Type: NIH

Study Record Dates

First Submitted

April 5, 2002

First Posted

April 8, 2002

Study Start

June 2001

Date type not reported

This date has not been verified as actual or estimated.

Study Completion

December 2002

Date type not reported

This date has not been verified as actual or estimated.

NCT00033059

Assessment of Potential Interactions Between Cocaine and Tolcapone - 1

Phase 1Unknown

NCT00136825

Effectiveness of N-acetylcysteine in Treating Cocaine Dependent Individuals - 1

Phase 1Completed

NCT00087750

Interaction Between Cocaine and Quetiapine - 1

Phase 1Unknown

NCT00000348

Infusion Laboratory: Protocol 4 (Dihydrexidine) - 13

Phase 1Unknown

NCT00000325

Psychostimulant Abuse - Novel Treatment Approaches - 1

Phase 1Completed

NCT00015067

Cocaine-Methylphendidate Interaction Study - 4

Phase 1Completed

Incapable of understanding the informed consent process; Additional criteria available during screening at the site.

Contact the study team to confirm eligibility.

Last Updated

January 11, 2017

Record last verified: 2004-04

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT00032916
Data provider: ClinicalTrials.gov
Source updated: 2017-01-11
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:37:44 UTC

Locations

US(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Study Completion

Conditions

Outcome Measures

Primary Outcomes (2)

Interventions

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Interventions

Condition Hierarchy (Ancestors)

Study Officials

Study Design

Study Record Dates

Source record

Locations